News

American Association of Individual Investors5d
Why Akoya Biosciences, Inc.’s (AKYA) Stock Is Down 7.20%
Akoya Biosciences, Inc.’s AKYA share price has dipped by 7.20%, which has investors questioning if this is right time to buy.
Akoya Biosciences price target lowered to $1.65 from $2.40 at Piper Sandler
Piper Sandler analyst David Westenberg lowered the firm’s price target on Akoya Biosciences (AKYA) to $1.65 from $2.40 and keeps a Neutral ...
Piper Sandler Remains a Hold on Akoya Biosciences (AKYA)
Piper Sandler analyst David Westenberg maintained a Hold rating on Akoya Biosciences (AKYA – Research Report) today and set a price target of ...
Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders
Kent Lake PR LLC ("Kent Lake"), a holder of approximately 7.7% of the outstanding common stock of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTRX), today announced that it has filed ...
The Joplin Globe6d
Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences
Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences ...
Joplin Globe3d
Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders
Kent Lake PR LLC (“Kent Lake”), a holder of approximately 7.7% of the outstanding common stock of Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), today announced ...